| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Medizinische Universitätsklinik B, Kantonsspital Basel, Basel, Switzerland
The low levels of complement receptor 1 (CR1) on erythrocytes in autoimmune diseases and AIDS may be due to accelerated loss in the circulation, or to a diminished expression of CR1 on the red cell lineage. Therefore, we analyzed the expression of CR1 on reticulocytes (R) vs erythrocytes (E). Healthy subjects had a significant higher CR1 number per cell on R (919 ± 99 CR1/cell) than on E (279 ± 30 CR1/cell, n = 23), which corresponded to a 3.5- ± 1.3-fold loss of CR1. This intravascular loss was confirmed by FACS analysis, which showed that all R expressed CR1, whereas a large fraction of E was negative. The systemic lupus erythematosus (SLE), HIV-infected, and cold hemolytic Ab disease (CHAD) patients had a CR1 number on R identical to the healthy subjects, contrasting with a lower CR1 on their E. The data indicated a significantly higher loss of CR1 in the three diseases, i.e., 7.0- ± 3.8-, 6.1- ± 2.9-, and 9.6- ± 5.6-fold, respectively. The intravascular loss was best exemplified in a patient with factor I deficiency whose CR1 dropped from 520 CR1/R to 28 CR1/E, i.e., 18.6-fold loss. In one SLE patient and in the factor I-deficient patient, the FACS data were consistent with a loss of CR1 already on some R. In conclusion, CR1 is lost progressively from normal E during in vivo aging so that old E are almost devoid of CR1. The low CR1 of RBC in autoimmune diseases and HIV-infection is due to a loss occurring in the circulation by an active process that remains to be defined.
This article has been cited by other articles:
|
|
 |
|
  S. Sadallah, C. Eken, and J. A. Schifferli Erythrocyte-derived ectosomes have immunosuppressive properties J. Leukoc. Biol., November 1, 2008; 84(5): 1316 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Giannouli, M Voulgarelis, P D Ziakas, and A G Tzioufas Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment Ann Rheum Dis, February 1, 2006; 65(2): 144 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Horakova, O. Gasser, S. Sadallah, J. M. Inal, G. Bourgeois, I. Ziekau, T. Klimkait, and J. A. Schifferli Complement Mediates the Binding of HIV to Erythrocytes J. Immunol., September 15, 2004; 173(6): 4236 - 4241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tamano, H. Ohi, S. Sudo, and Y. Tomino Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1467 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zorzetto, C. Bombieri, I. Ferrarotti, S. Medaglia, C. Agostini, C. Tinelli, G. Malerba, N. Carrabino, A. Beretta, L. Casali, et al. Complement Receptor 1 Gene Polymorphisms in Sarcoidosis Am. J. Respir. Cell Mol. Biol., July 1, 2002; 27(1): 17 - 23. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
